Hongwei Wang
7PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 07, 2025
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial.Da Xu, Hongwei Wang, Quan Bao
|Feb 27, 2023
Five-year survival post hepatectomy for colorectal liver metastases in a real-world Chinese cohort: Recurrence patterns and prediction for potential cure.Yu-Ming Su, Wei Liu, Xiao-Luan Yan
|Nov 10, 2022
Impact of Age of Onset on Survival after Hepatectomy for Patients with Colorectal Cancer Liver Metastasis: A Real-World Single-Center Experience.Hong-Wei Wang, Li-Jun Wang, Ke-Min Jin
|Jul 21, 2022
Postoperative complications predict poor outcomes only in patients with a low modified clinical score after resection of colorectal liver metastases: a retrospective cohort study.Hong-Wei Wang, Ke-Min Jin, Juan Li
|Feb 16, 2022
Prognostic value of the combination of primary tumor location and RAS mutational status on patients with colorectal liver metastasis undergoing hepatectomy.Xiao-Luan Yan, Kun Wang, Quan Bao
|Feb 01, 2022
Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial.Kanglian Zheng, Xu Zhu, Shijie Fu
Pageof 2
